3P Biopharmaceuticals Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
350
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
3P Biopharmaceuticals General Information
Description
Operator of a contract manufacturing firm intended to offer biologics and cell therapy products. The company develops recombinant proteins for therapeutic and diagnostic uses as well as offers monoclonal antibodies, proteins, interleukins, vaccines and biosimilars, enabling clients to get safe and advanced medicines to improve lives.
Contact Information
Website
www.3pbio.comCorporate Office
- Poligono Industrial Mocholi
- C/Mocholí 2
- 31110 Noain
- Spain
Corporate Office
- Poligono Industrial Mocholi
- C/Mocholí 2
- 31110 Noain
- Spain
3P Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
3P Biopharmaceuticals Comparisons
Industry
Financing
Details
3P Biopharmaceuticals Competitors (24)
One of 3P Biopharmaceuticals’s 24 competitors is Cambrex, a Private Equity-Backed company based in East Rutherford, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cambrex | Private Equity-Backed | East Rutherford, NJ | ||||
| Patheon | Formerly PE-Backed | Waltham, MA | ||||
| Skyepharma | Private Equity-Backed | Saint Quentin Fallavier, France | ||||
| Unither Pharmaceuticals | Private Equity-Backed | Amiens, France | ||||
| Alcami | Private Equity-Backed | Wilmington, NC |
3P Biopharmaceuticals Patents
3P Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2523016-B1 | Alpha-viral vectors and cell lines for the production of recombinant proteins | Inactive | 20-May-2013 | ||
| EP-3000890-A1 | Alphaviral vectors and cell lines for producing recombinant proteins | Active | 20-May-2013 | ||
| EP-3000890-A4 | Alphaviral vectors and cell lines for producing recombinant proteins | Active | 20-May-2013 | ||
| EP-3000890-B1 | Alphaviral vectors and cell lines for producing recombinant proteins | Active | 20-May-2013 | ||
| ES-2523016-A1 | Alphaviral vectors and cell lines for producing recombinant proteins | Active | 20-May-2013 | C12N15/86 |
3P Biopharmaceuticals Signals
3P Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
3P Biopharmaceuticals FAQs
-
When was 3P Biopharmaceuticals founded?
3P Biopharmaceuticals was founded in 2006.
-
Where is 3P Biopharmaceuticals headquartered?
3P Biopharmaceuticals is headquartered in Noain, Spain.
-
What is the size of 3P Biopharmaceuticals?
3P Biopharmaceuticals has 350 total employees.
-
What industry is 3P Biopharmaceuticals in?
3P Biopharmaceuticals’s primary industry is BPO/Outsource Services.
-
Is 3P Biopharmaceuticals a private or public company?
3P Biopharmaceuticals is a Private company.
-
What is 3P Biopharmaceuticals’s current revenue?
The current revenue for 3P Biopharmaceuticals is .
-
How much funding has 3P Biopharmaceuticals raised over time?
3P Biopharmaceuticals has raised $14.8M.
-
Who are 3P Biopharmaceuticals’s investors?
Activos y gestion accionarial, Cinamar, Clave (Pamplona), CorporacciónCan - Grupo Corporativo Empresarial Caja Navara, and DRO Biossystems are 5 of 11 investors who have invested in 3P Biopharmaceuticals.
-
Who are 3P Biopharmaceuticals’s competitors?
Cambrex, Patheon, Skyepharma, Unither Pharmaceuticals, and Alcami are some of the 24 competitors of 3P Biopharmaceuticals.
-
When was 3P Biopharmaceuticals acquired?
3P Biopharmaceuticals was acquired on 19-Jul-2019.
-
Who acquired 3P Biopharmaceuticals?
3P Biopharmaceuticals was acquired by 3PBiovian.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process